Showing results (121-130 of 438) with videos related to

Sort By:
Pageof 44
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|November 16, 2020
Impact of Aspirin on clinical outcome in advanced HCC patients receiving sorafenib and regorafenibAndrea Casadei-Gardini, Giulia Rovesti, Vincenzo Dadduzio, et al.
International Journal of Surgery (London, England)|February 20, 2022
Multimodal treatment of radiation-induced esophageal cancer: Results of a case-matched comparative study from a single centerElisa Sefora Pierobon, Giovanni Capovilla, Lucia Moletta, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 5, 2025
Epstein-Barr Virus-associated gastric cancer: a histopathologic study with comprehensive molecular profilingValentina Angerilli, Jessica Gasparello, Antonio Collesei, et al.
Clinical Colorectal Cancer|July 2, 2020
KRAS G12C Metastatic Colorectal Cancer: Specific Features of a New Emerging Target PopulationMarta Schirripa, Floriana Nappo, Chiara Cremolini, et al.
Plos One|December 4, 2015
HLA-G 3'UTR Polymorphisms Impact the Prognosis of Stage II-III CRC Patients in Fluoropyrimidine-Based TreatmentMarica Garziera, Ettore Bidoli, Erika Cecchin, et al.
The Lancet. Gastroenterology & Hepatology|May 19, 2026
Management of colorectal cancer in older adults: an expert panel recommendation to guide daily clinical practiceGabor Liposits, Thierry André, Thomas Aparicio, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 4, 2025
Locoregional treatment of esophageal oligometastatic disease to the liver: single center experience, a systematic review and meta-analysisGiulia Nezi, Matteo Pittacolo, Lucia Moletta, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|April 9, 2025
Heterogeneity of predictive biomarker expression in gastric and esophago-gastric junction carcinoma with peritoneal disseminationValentina Angerilli, Matilde Callegarin, Ilaria Govoni, et al.
Tumori|January 30, 2025
Emerging therapeutic strategies in Lynch syndrome-associated colorectal cancer and the role of MMR testingSilvia Negro, Eleonora Perissinotto, Isabella Mammi, et al.
The Lancet. Oncology|June 17, 2023
Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses from a single-arm, phase 2 studyEric Van Cutsem, Maria di Bartolomeo, Elizabeth Smyth, et al.
Pageof 44